How much is Chimera Bioengineering worth in 2026?

Chimera Bioengineering has a current valuation of N/A based on their Later Stage VC (Series A) round and secondary market data.

How much funding has Chimera Bioengineering raised?

Chimera Bioengineering has raised N/A in total funding across 1 funding rounds.

Chimera Bioengineering

Drug Discovery

Chimera Bioengineering valuation and funding history | Last updated: February 9, 2022 | 1 funding rounds

Current Valuation

N/A

As of February 9, 2022

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series A)

$23.8M

Last Funding

Feb 2022

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 9, 2022	Later Stage VC (Series A)	$23.8M	N/A	-

Valuation Analysis

Current Valuation Metrics

Chimera Bioengineering is currently valued at N/A as of February 9, 2022.

Track Chimera Bioengineering Valuation Updates

Get notified when Chimera Bioengineering raises new funding or valuation changes

Explore More Data

Detailed analysis for Chimera Bioengineering

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Chimera Bioengineering's valuation history, funding rounds, and growth metrics.

No credit card required

What is Chimera Bioengineering Worth in 2026?

Chimera Bioengineering is a leading private company in the Drug Discovery sector. Track Chimera Bioengineering's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Chimera Bioengineering Valuation is Determined

Private company valuations like Chimera Bioengineering's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.